FDC make modest beginning in 1936, with marketing of vitamins and a range of prescription formulations. FDC set up its first formulations manufacturing facility in 1949. Subsequently, in 1963, FDC pioneered the manufacture of specialized ophthalmic formulations in India. FDC was the first organization to introduce the BFS (Blow-Fill-Seal) technology for ophthalmic in South East Asia. In 1972, FDC initiated the concept of Oral Rehydration Salts (ORS). Today its pioneer brand ‘Electral’ stands apart with a special identity- an impressive achievement in a fiercely competitive market. FDC’s API plant at Roha (Maharashtra) was among the first few API facilities in India to get US-FDA approval in 1984. Since then, FDC has to its credit a number of new molecules, introduced for the first time in the nation.

Today, FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few. FDC is a forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmics. FDC has also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. These facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh. FDC markets hundreds of products in India and exports many of these to various countries.

Business area of the company

FDC Limited is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.

FDC Ltd.

Aarti Drugs Ltd.

Glenmark Life Sciences Ltd.

Hikal Ltd.

Caplin Point Laboratories Ltd.

Indoco Remedies Ltd.

Wockhardt Ltd.

Jubilant Pharmova Ltd.

AMI Organics Ltd.

Advanced Enzyme Technologies Ltd.

Unichem Laboratories Ltd.

Strides Pharma Science Ltd.

Shilpa Medicare Ltd.

Procter & Gamble Health Ltd.

Sequent Scientific Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	4,650 Cr		EPS	10.3		High	291.5
Stock P/E	27.3		Net Profit Margin	11.6		Low	286

Market Cap	4,650 Cr	ROE	11.7%
P/E Ratio(TTM)	27.3	EPS(TTM)	11.4
P/B Ratio	2.5	Dividend Yield	0.0%
Industry P/E	63.6	Book Value	114.2
		Face Value	1.0